Sign inGet started

Turka Laurence A.

Insider CIK 1800952 · RUBY Chief Scientific Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RUBY Rubius Therapeutics, Inc. M Exercise deriv2023-01-312023-01-318,625— $025,875SEC↗
RUBY Rubius Therapeutics, Inc. S Sale2023-01-312023-01-312,593$0.24 $62218,391SEC↗
RUBY Rubius Therapeutics, Inc. M Exercise2023-01-312023-01-318,625— $020,984SEC↗
RUBY Rubius Therapeutics, Inc. M Exercise deriv2023-01-292023-01-317,438— $014,874SEC↗
RUBY Rubius Therapeutics, Inc. M Exercise2023-01-292023-01-317,438— $012,359SEC↗
RUBY Rubius Therapeutics, Inc. S Sale2022-02-012022-02-012,517$6.57 $16.5K4,921SEC↗
RUBY Rubius Therapeutics, Inc. A Award deriv2022-01-312022-02-01143,750— $0143,750SEC↗
RUBY Rubius Therapeutics, Inc. A Award deriv2022-01-312022-02-0134,500— $034,500SEC↗
RUBY Rubius Therapeutics, Inc. M Exercise deriv2022-01-292022-02-017,438— $022,312SEC↗
RUBY Rubius Therapeutics, Inc. M Exercise2022-01-292022-02-017,438— $07,438SEC↗
RUBY Rubius Therapeutics, Inc. A Award deriv2021-01-292021-02-02131,250— $0131,250SEC↗
RUBY Rubius Therapeutics, Inc. A Award deriv2021-01-292021-02-0229,750— $029,750SEC↗
RUBY Rubius Therapeutics, Inc. A Award deriv2020-01-312020-02-03350,000— $0350,000SEC↗